Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ <scp>GemOx</scp> in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( <scp>TRUST</scp> ): A Multicenter, Single‐Arm, Phase 2 Trial
Beijing Xisike Clinical Oncology Research Foundation
National Natural Science Foundation of China
National Key Research and Development Program of China
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( TRUST ): A Multicenter, Single‐Arm, Phase 2 Trial
Bingyi Wu, Zhiming Li, Danling Dai, Peng Sun et al.
Citations
4 citations
Journal
Cancer Medicine
Topics
Histone Deacetylase Inhibitors Research
Field-Weighted Citation Impact (FWCI)
3.22
article
Chidamide, a Histone Deacetylase Inhibitor, Combined With R‐ GemOx in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma ( TRUST ): A Multicenter, Single‐Arm, Phase 2 Trial
Bingyi Wu, Zhiming Li, Danling Dai, Peng Sun, Yingxian Liu, Liye Zhong, Yuhong Lu, Qingqing Cai, Hui Zhou, Yi Cao, Runhui Zheng, Ning Su, Panpan Liu, Wenyu Li, Yuchen Zhang, Yongfeng Yang, Huo Tan, Liang Yang, Xu Ye, Yudan Wu, Lirong Li, Huiqiang Huang, Yi Xia, Qihua Zou, Y.C. Lai
article en
4 citations
Abstract
No abstract available for this paper.
Publication Tag
Cancer MedicineVol. 14(9)
Institutions
Guangzhou University of Chinese Medicine (CN), Sun Yat-sen University (CN), Second Affiliated Hospital of Guangzhou Medical University (CN), Sun Yat-sen Memorial Hospital (CN), First Affiliated Hospital of Guangzhou Medical University (CN), The First People's Hospital of Shunde (CN), Hunan Cancer Hospital (CN), Sun Yat-sen University Cancer Center (CN), Guangdong Provincial People's Hospital (CN), Guangzhou Chest Hospital (CN), Southern Medical University (CN), Guangzhou Medical University (CN)
Funders
Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China, National Key Research and Development Program of China